Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 1 (2004), Issue 4 (November)

1. The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging.
   Stat Med, 23(21): 3275-86. [Abstract] [Full-text]
2. Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population.
   Am J Med Genet B Neuropsychiatr Genet, 131(1): 60-6. [Abstract] [Full-text]
3. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
   Neurosci Lett, 371(2): 142-6. [Abstract] [Full-text]
4. Alzheimer's beta-peptide oligomer formation at physiologic concentrations.
   Anal Biochem, 335(1): 81-90. [Abstract] [Full-text]
5. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
   Pharmacol Res, 51(1): 1-17. [Abstract] [Full-text]
6. Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese.
   Neurosci Lett, 372(1): 27-9. [Abstract] [Full-text]
7. Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism.
   Brain Res Mol Brain Res, 131(1): 88-92. [Abstract] [Full-text]
8. Transferrin neutralization of amyloid beta 25-35 cytotoxicity.
   Clin Chim Acta, 350(1): 129-36. [Abstract] [Full-text]
9. Abeta N-terminal-end specific antibody reduced beta-amyloid in Alzheimer-model mice.
   Biochem Biophys Res Commun, 325(2): 384-7. [Abstract] [Full-text]
10. Prevention of Alzheimer's disease-associated Abeta aggregation by rationally designed nonpeptidic beta-sheet ligands.
    J Biol Chem, 279(46): 47497-505. [Abstract] [Full-text]
11. Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease.
    J Geriatr Psychiatry Neurol, 17(4): 225-31. [Abstract] [Full-text]
12. Neuropsychosocial features of very mild Alzheimer's disease (CDR 0.5) and progression to dementia in a community: the Tajiri project.
    J Geriatr Psychiatry Neurol, 17(4): 183-9. [Abstract] [Full-text]
13. Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data.
    Arch Clin Neuropsychol, 19(8): 1007-15. [Abstract] [Full-text]
14. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1.
    Med Hypotheses, 64(1): 53-8. [Abstract] [Full-text]
15. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
    J Neurosci, 24(45): 10191-200. [Abstract] [Full-text]
16. Lipids, diet and Alzheimer disease: an extended summary.
    J Neurol Sci, 226(1): 31-3. [Abstract] [Full-text]
17. Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity.
    Neuropathol Appl Neurobiol, 30(6): 676-82. [Abstract] [Full-text]
18. Alzheimer's disease Abeta peptide fragment 10-30 forms a spectrum of metastable oligomers with marked preference for N to N and C to C monomer termini proximity.
    J Mol Biol, 344(4): 1037-49. [Abstract] [Full-text]
19. Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients.
    J Neurol Neurosurg Psychiatry, 75(12): 1746-8. [Abstract] [Full-text]
20. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel.
    J Neurol Sci, 227(1): 109-13. [Abstract] [Full-text]
21. Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease.
    Neurosci Lett, 373(1): 1-4. [Abstract] [Full-text]
22. GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons.
    J Biol Chem, 279(48): 50176-80. [Abstract] [Full-text]
23. An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer's disease.
    Acta Neuropathol (Berl), 108(6): 538-45. [Abstract] [Full-text]
24. Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
    Mol Psychiatry, 9(12): 1122-8, 1059. [Abstract] [Full-text]
25. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.
    J Biol Chem, 279(49): 51451-9. [Abstract] [Full-text]
26. NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain.
    Neurosci Lett, 373(2): 115-8. [Abstract] [Full-text]
27. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease.
    Neurosci Res, 50(4): 481-4. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.